HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Dolunay Gülmez Selected Research
Dolunay Gülmez Research Topics
Disease
8
Infections
01/2024 - 06/2008
2
Mycoses (Diseases, Fungus)
04/2023 - 01/2021
2
Necrotizing Pneumonia
04/2023 - 10/2011
2
Candidemia
08/2021 - 10/2016
1
Rhinosinusitis
01/2024
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2024
1
Hemolysis
01/2024
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2023
1
Neoplasms (Cancer)
04/2023
1
Dyspnea (Shortness of Breath)
04/2023
1
Coinfection
07/2022
1
Soft Tissue Infections
07/2012
1
Pneumonia (Pneumonitis)
10/2011
1
Myalgia
10/2011
1
Respiratory Insufficiency (Respiratory Failure)
10/2011
1
Fever (Fevers)
10/2011
1
Empyema
10/2011
1
Cough
10/2011
1
Rheumatic Diseases (Rheumatism)
04/2003
1
Rheumatoid Arthritis
04/2003
Drug/Important Bio-Agent (IBA)
3
Fluconazole (Zonal)
FDA Link
Generic
04/2023 - 01/2021
1
posaconazole
FDA Link
01/2024
1
Esterases
IBA
01/2024
1
Phospholipases (Phospholipase)
IBA
01/2024
1
Peptide Hydrolases (Proteases)
FDA Link
01/2024
1
Acids
IBA
01/2024
1
Coagulase
IBA
01/2024
1
Antifungal Agents
IBA
04/2023
1
Azoles
IBA
04/2023
1
Immune Checkpoint Inhibitors
IBA
04/2023
1
pembrolizumab
IBA
04/2023
1
Chlorhexidine
IBA
07/2022
1
Povidone-Iodine (Betadine)
FDA Link
Generic
07/2022
1
mesoglycan
IBA
01/2022
1
Anidulafungin
FDA Link
08/2021
1
Caspofungin (Cancidas)
FDA Link
08/2021
1
Echinocandins
IBA
01/2021
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2021
1
Biocompatible Materials (Biomaterials)
IBA
04/2016
1
Virulence Factors (Pathogenicity Factors)
IBA
07/2012
1
Panton-Valentine leukocidin
IBA
07/2012
1
Clindamycin (Cleocin)
FDA Link
Generic
10/2011
1
Meropenem (Merrem)
FDA Link
Generic
10/2011
1
Linezolid (Zyvox)
FDA Link
10/2011
1
Clarithromycin (Biaxin)
FDA Link
Generic
10/2011
1
Levofloxacin (Levaquin)
FDA Link
10/2011
1
Carbapenems (Carbapenem Antibiotics)
IBA
06/2008
1
beta-Lactamases (beta-Lactamase)
IBA
06/2008
1
Biomarkers (Surrogate Marker)
IBA
04/2003
1
Anti-Citrullinated Protein Antibodies
IBA
04/2003
Therapy/Procedure
3
Therapeutics
10/2016 - 10/2010
1
Induction Chemotherapy
01/2024
1
Drug Therapy (Chemotherapy)
04/2023
1
Continuous Ambulatory Peritoneal Dialysis (CAPD)
01/2022
1
Catheters
01/2022
1
Withholding Treatment
10/2011
1
Chest Tubes (Chest Tube)
10/2011